Portal de investigação
ceRNA Network of lncRNA/miRNA as Circulating Prognostic Biomarkers in Non-Hodgkin Lymphomas: Bioinformatic Analysis and Assessment of Their Prognostic Value in an NHL Cohort
Data de publicação:
Autores da FMUP
Participantes de fora da FMUP
- Fernandes, M
- Marques, H
- Teixeira, AL
Abstract
Research has been focusing on identifying novel biomarkers to better stratify non-Hodgkin lymphoma patients based on prognosis. Studies have demonstrated that lncRNAs act as miRNA sponges, creating ceRNA networks to regulate mRNA expression, and its deregulation is associated with lymphoma development. This study aimed to identify novel circulating prognostic biomarkers based on miRNA/lncRNA-associated ceRNA network for NHL. Herein, bioinformatic analysis was performed to construct ceRNA networks for hsa-miR-150-5p and hsa-miR335-5p. Then, the prognostic value of the miRNA-lncRNA pairs' plasma levels was assessed in a cohort of 113 NHL patients. Bioinformatic analysis identified MALAT1 and NEAT1 as hsa-miR-150-5p and has-miR-335-5p sponges, respectively. Plasma hsa-miR-150-5p/MALAT1 and hsa-miR335-5p/NEAT1 levels were significantly associated with more aggressive and advanced disease. The overall survival and progression-free survival analysis indicated that hsa-miR-150-5p/MALAT1 and hsa-miR335-5p/NEAT1 pairs' plasma levels were remarkably associated with NHL patients' prognosis, being independent prognostic factors in a multivariate Cox analysis. Low levels of hsa-miR-150-5p and hsa-miR-335-5p combined with high levels of the respective lncRNA pair were associated with poor prognosis of NHL patients. Overall, the analysis of ceRNA network expression levels may be a useful prognostic biomarker for NHL patients and could identify patients who could benefit from more intensive treatments.
Dados da publicação
- ISSN/ISSNe:
- 1661-6596, 1661-6596
- Tipo:
- Article
- Páginas:
- 201-
- DOI:
- 10.3390/ijms23010201
- Link para outro recurso:
- www.scopus.com
International Journal of Molecular Sciences Multidisciplinary Digital Publishing Institute (MDPI)
Citações Recebidas na Web of Science: 7
Citações Recebidas na Scopus: 12
Documentos
- Não há documentos
Filiações
Keywords
- non-hodgkin lymphoma; miRNA; lncRNA; ceRNA network; prognosis; biomarker
Proyectos asociados
Previsão das readmissões dos doentes à Urgência Pediátrica: aplicação das técnicas de aprendizagem supervisionadas.
Investigador Principal: Rui Manuel de Medeiros Melo Silva
Estudo Observacional Académico (UrgPediatr) . 2019
Identificação de determinantes farmacogenómicas preditivas de resposta ao tratamento em doentes com cancro do colo do útero
Investigador Principal: Rui Manuel de Medeiros Melo Silva
Estudo Clínico Académico . 2021
Pharmacoepigenomic profile of ovarian cancer patients submitted to taxane-based chemoteherapy
Investigador Principal: Rui Manuel de Medeiros Melo Silva
Estudo Clínico Académico . 2020
Anal squamous intraepithelial lesions
Investigador Principal: Rui Manuel de Medeiros Melo Silva
Estudo Clínico Académico . 2020
Characterization of Pain and Genetic Variants Associated with Pain in Patients with Metastatic Bone Disease
Investigador Principal: Rui Manuel de Medeiros Melo Silva
Estudo Clínico Académico . 2019
Citar a publicação
Fernandes M,Marques H,Teixeira AL,Medeiros R. ceRNA Network of lncRNA/miRNA as Circulating Prognostic Biomarkers in Non-Hodgkin Lymphomas: Bioinformatic Analysis and Assessment of Their Prognostic Value in an NHL Cohort. Int. J. Mol. Sci. 2022. 23. (1):p. 201-201. IF:5,600. (1).
